Home -> Law Blog Directory -> Corporate Governance Blogs -> The Race to the Bottom
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Corporate Governance
: The Race to the BottomThe Director Compensation Project: Johnson & Johnson
By Laura Almquist
This post is part of an ongoing series that examines the way stock exchange independence rules influence director compensation. We are including companies from 2007’s Fortune 100 and using information disclosed in each company’s 2008 proxy statements. In addition to state standards and the requirements of SOX, the stock exchanges have each adopted their own standards for director independence. Meeting stock exchange requirements is mandatory for most listed companies.
Under NYSE Rule 303A.01, all listed companies must have a majority of independent directors sitting on their boards. Directors are not independent if they received over $100,000 in direct compensation, other than director’s fees, in any one year period over the last three years pursuant to Rule 303A.02(b)(ii). This is a looser restriction than the equivalent NASDAQ Rule, 4200(a)(15), which includes all compensation. Rule 303A.06 requires that, in addition to the general independence standards, audit committee members must comport with the requirements of Exchange Act Rule 10A-3 (C.F.R. §240.10A-3), also known as SOX 301.
One can see some of the effects of these rules when looking at the director compensation table from Johnson & Johnson’s (JNJ-NYSE) 2008 proxy statement.
Name | Fees Earned or Paid in Cash | Stock Awards | Option Awards | All Other Compensation | Total |
M.S. Coleman | 95,000 | 99,939 | — | 7,692 | 202,631 |
J.G. Cullen | 115,000 | 99,939 | — | 7,692 | 222,631 |
M.M.E. Johns | 96,500 | 99,939 | — | 5,244 | 201,683 |
A.D. Jordan | 36,500 | 99,939 | — | 7,692 | 144,131 |
A.G. Langbo | 106,500 | 99,939 | — | 7,692 | 214,131 |
S.L. Lindquist | 95,000 | 99,939 | — | 7,692 | 202,631 |
L.F. Mullin | 105,000 | 99,939 | — | 7,692 | 212,631 |
W.D. Perez | 52,750 | 61,790 | — | — | 114,540 |
C. Prince | 96,500 | 99,939 | — | 2,467 | 198,906 |
S.S. Reinemund | 103,167 | 99,939 | — | 7,692 | 210,798 |
D. Satcher | 105,000 | 99,939 | — | 7,692 | 212,631 |
Director Compensation . Five directors received more than $100,000 in director’s fees paid in cash, and the non-employee directors as a group averaged $194,304 in total compensation for their services. As can be seen in the table, much of the directors’ compensation came in the form of stock awards, which are considered director’s fees for purposes of complying with exchange rules.
Director Tenure . On average, the non-employee directors have served on the board for 6.5 years. Arnold G. Lango has the longest tenure at seventeen years. Eight of the directors also sit on other boards. One director alone sits on the boards at American Express, Exxon Mobil, and Marriot International.
CEO Compensation . The CEO, William C. Weldon, received $31,916,566 in total compensation last year, a relatively small portion of which came in the form of cash ($1,725,000). Over $3,000,000 of his compensation came from "other compensation," which mostly included dividends equivalents earned as part of a non-equity compensation plan. Almost one third ($9,188,120) of his compensation was tied to non-equity performance incentives and another third ($9,8954,532) was in the form of stock and options awards, the value of which was dependent upon company performance. Change in pension value and other deferred compensation comprised the remaining $7,888,757 of Mr. Weldon’s pay.
Full post as published by The Race to the Bottom on May 07, 2008 (boomark / email).
Bextra Injury Risks
Bextra Increases Risk of Fatal Heart Attack
Workers Compensation Overview
Federal laws that cover workplace injuries
Johnson & Johnson 401(k) / ERISA Stock Fraud
Johnson & Johnson 401(k) / ERISA Stock Fraud
SJS, Stevens Johnson Syndrome
alleging that certain drugs cause this deadly skin inflammation.
Advil - Ibuprofen
allegedly leads to Stevens Johnson Syndrome and Toxic Epidermal Necrosis.
Ketek
allegedly causing potentially life threatening Stevens Johnson Syndrome (SJS) skin reaction.
Children's Motrin
allegedly causing Stevens Johnson Syndrome (SJS) potentially life threatening skin inflammations.
Investor Fraud
Company president and director Gregory William Rivers to pay $10,000 shareholder fraud settlement.

Johnson & Johnson Heirs Films Cause Discord among Family and Friends
Another day in the stent patent wars
Lessons From Johnson + Johnson
Thats Not the Protection We Had In Mind
Court Rules In Favor of Red Cross in Lawsuit with Johnson & Johnson
Johnson & Johnson Receives Subpoena on Bile Duct Stents









